Abingdon Health Plc (AIM:ABDX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
10.00
+0.15 (1.52%)
Jul 28, 2026, 8:07 AM GMT

Abingdon Health Income Statement

Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
9.578.436.144.052.8411.62
Revenue Growth
13.56%37.39%51.67%42.68%-75.60%121.93%
Cost of Revenue
5.614.692.461.976.437.48
Gross Profit
3.963.743.682.08-3.594.14
Selling, General & Admin
7.887.715.315.226.657.55
Other Operating Expenses
-1.81-1.67-0.50.4411.293.32
Total Operating Expenses
6.076.054.815.6617.9410.86
Operating Income
-3.15-3.51-1.37-3.59-21.53-6.72
Interest Income
0.070.10.030.090-
Interest Expense
-0.08-0.09-0.06-0.08-0.07-0.23
Total Non-Operating Income (Expense)
-0.010.01-0.030.01-0.07-0.23
Pretax Income
-3.16-3.5-1.4-3.57-21.59-6.95
Provision for Income Taxes
0.08-0.08-0.13-0.11-0.330.02
Net Income
-3.24-3.42-1.27-3.47-21.26-6.97
Net Income to Common
-3.24-3.42-1.27-3.47-21.26-6.97
Net Income Growth
------
Shares Outstanding (Basic)
387367305304292263
Shares Outstanding (Diluted)
387367305306292263
Shares Change
5.50%20.32%-0.36%4.87%10.91%5.03%
EPS (Basic)
-0.01-0.01-0.00-0.01-0.07-0.03
EPS (Diluted)
-0.01-0.01-0.00-0.01-0.07-0.03
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
-2.62-3.51-1.690.84-8.42-19.64
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.01-0.01-0.010.00-0.03-0.07
Gross Margin
41.38%44.32%59.97%51.30%-126.70%35.66%
Operating Margin
-32.92%-41.63%-22.38%-88.70%-759.37%-57.84%
Profit Margin
-33.88%-40.51%-20.72%-85.76%-749.98%-60.02%
FCF Margin
-27.36%-41.63%-27.61%20.72%-297.04%-169.02%
EBITDA
-2.47-2.91-0.95-2.81-12.7-5.97
EBITDA Margin
-25.75%-34.54%-15.44%-69.57%-447.94%-51.39%
EBIT
-3.15-3.51-1.37-3.59-21.53-6.72
EBIT Margin
-32.92%-41.63%-22.38%-88.70%-759.37%-57.84%
Effective Tax Rate
-2.59%2.32%9.15%2.94%1.53%-0.27%